Change of the number of shares and votes in Karo Pharma

STOCKHOLM, May 31, 2016 - Karo Pharma AB today announces that the com-pany’s total number of shares as per May 31, 2016 amounts to 63,907, 194 shares, corresponding to an equal number of votes. The increase in the number of shares and votes results from the recently completed share issues of 13,981,439 shares. Both issues were announced on February 12, 2016.



For further information, please contact:
Henrik Palm, CFO, telephone +46 70 540 40 14 or e-mail henrik.palm@karopharma.se

About Karo Pharma
Karo Pharma is a health care company focused on developing and marketing of products to pharmacies, fast-moving consumer goods and the health care directly. Karo Pharma is listed on Nasdaq Stockholm.

Karo Pharma publishes this information in accordance with the Swedish Securities Markets Act and/or the Swedish Instruments Trading Act. The information was submitted for publica-tion on May 31, 2016 at 15:00 CET.

This press release is also available on www.karopharma.se and www.newsroom.cision.com

Tags:

About Us

Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment.

Subscribe

Documents & Links